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Introduction
Malaria is a severe and potentially fatal parasitic disease that constitutes a major public health issue, being one of the greatest causes of mortality in tropical regions [1] . Pregnant women are particularly vulnerable to malaria infection and it is estimated that 125 million women are at risk of malaria in pregnancy (MiP) each year [1, 2] . Malaria can be devastating for both mother and fetus, leading up to 10,000 maternal and 75,000 to 200,000 child deaths each year [3] . Maternal malaria presents a significant impact on the neonates, being associated with increased risk of spontaneous abortion, stillbirth, premature delivery, fetal death, low birth weight (LBW) and fetal/child development retardation in malaria-endemic countries [1, 3] .
LBW reflects an intra-uterine growth retardation (IUGR) and preterm delivery, which are compelling indicators of infant morbidity [3] [4] [5] [6] . LBW has been linked to infant mortality and poor cognitive development, and the occurrence of non-communicable diseases later in life [6, 7] . In fact, LBW due to malaria is related with up to 100,000 infant deaths each year in endemic countries [8, 9] . These adverse birth outcomes have been extensively associated with P. falciparum infection during pregnancy. In contrast to P. falciparum, the P. vivax burden in pregnancy is less well described, and have been described as having less impact in the newborn [3, 10] . Though, recent studies have presented the two species as similar threats to the mother and fetus [11, 12] . Despite the efforts to reduce malaria the prevalence of these adverse birth outcomes remains high.
Therefore, it is crucial to have an efficient epidemiological surveillance of malaria during pregnancy. The linkage of two or more health public surveillance record databases with shared variables presents an important and effective strategy to plan preventive measures. Currently, most of the malaria-endemic countries have malaria public surveillance record databases since it is compulsory notification disease. This will contribute to the identification of epidemics and areas most affected. Thus, allowing to direct and intensify the control and preventive measures to the affected communities, and reduce negative birth outcomes [13] . In fact, due to the potential assemble with other information systems it can be recognized as an important tool for research [14] [15] [16] .
In 2003, the Brazilian Epidemiological Surveillance Information System (SIVEP)-Malaria was implemented to systematize the flow and quality of the information on malaria. This system gathers information on malaria morbidity according to gender, age, Plasmodium species, site of residence, the probable site of infection, treatment, and pregnancy status [17] . Another essential Brazilian information system of national coverage is the Information System of Live Births (SINASC), implemented in 1990. This system collects and systematizes information on maternal, pregnancy, delivery and newborn data [18] , [19] . Linkage of record databases is still scarcely used in Brazil, despite being an easy to perform technique with low operational cost. Here we present the first study that evaluates the association between MiP and adverse birth outcomes in the Brazilian Amazonian region for nine years (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) , using information obtained through the linkage of SINASC and SIVEP-Malaria.
Materials and methods

Study design and data collection
This is a population-based observational study developed in the city of Cruzeiro do Sul-Acre (Brazil), located in the Brazilian Amazonian region (7˚37'51"S, 72˚40'12"W) (Fig 1) . Cruzeiro do Sul has an estimated population of 82,075 inhabitants and an average of 1,650 births per year [20] . Together with Porto Velho and Manaus, the three cities are responsible for 21.9% of the malaria cases notified in Brazil [21] . It is a high transmission risk city, with an annual parasitic incidence of 214 cases per 1,000 inhabitants, with the prevalence of P. vivax infection [21] . The universe of the studied population was composed of all live newborns delivered by women living in the city, between January 2006 and December 2014. The information regarding the mother, newborn and delivery was extracted from SINASC, and the information on the malaria episodes and parasite species was obtained from the SIVEP-Malaria. By knowing that the primary health care is provided free of cost in Brazil and that the information systems of the Ministry of Health (MoH) offer wide coverage, we can presume that these datasets are reliable.
Ethical considerations
The consent to use this dataset was granted by the Secretaries of Health from the State of Acre and from the city of Cruzeiro do Sul after signing the Term of Commitment for the Use of Data from Medical Records under the agreement of maintaining confidentiality and safety of the collected data from the medical records and databases. The nominal data was strictly used for the record linkage, being the deidentification done before data analysis. In accordance, this study is in agreement with the Resolution nº 196/96 of the Brazilian National Health 
Exclusion criteria
In this study, the SINASC database was considered the reference. Before performing the record linkage, curation was performed, and newborns with double entries, lack of information on birth weight, presenting congenital diseases or twins were excluded. Upon the linkage of SINASC with SIVEP-Malaria database, newborns with less than 22 weeks' gestational age (miscarriage) or with no information on the gestational age at birth were excluded (Fig 2) .
Screening of malaria infection
In Brazil, whenever individual show suspicious malaria symptoms, it is tested by qualified endemic agents that monitor micro-regions. The gold standard method for malaria diagnosis is the thin and thick blood smear, which is screened by trained microscopists from the System of Epidemiological Surveillance of the MoH, and further revised by senior experts, to confirm the results. Infections were categorized per parasite species: P. falciparum, P. vivax, or mixed infections. All women who had malaria during pregnancy were treated with antimalarial drugs under medical prescription, according to the Brazilian MoH guidelines.
Definitions and gestational age estimation
LBW was defined as birth weight < 2500 grams (g). WHO child growth standards were used to classify the small for gestational age newborns, weight 10th centile (boys 2758 g, girls 2678g). The very preterm birth was defined as birth between !28 and <32 weeks' gestation; late preterm birth was defined as birth between !32 and <37 weeks' gestation, and total preterm birth was defined as birth <37 weeks' gestation [22] . The gestational age was established by the woman's last menstrual period and, when possible, adjusted by ultrasound during antenatal visit care. In SINASC database, gestational age is categorized as follows: less than 22 weeks' gestation, 22-27 weeks, 28-31 weeks, 32-36 weeks, 37-41 weeks, and 42 weeks or more.
Record linkage strategy
The record linkage was performed by using the RecLink III software [23] through the deterministic method (manual search). For the data preprocessing, standardization of both databases was performed by withdrawing accentuations, extra spaces, special characters, and prepositions. After, databases were unified only by two shared variables that presented the appropriate fulfillment. Each year of the record linkage corresponds to one year of the SINASC (containing births records) assembled with two years of the SIVEP-Malaria, to identify all malaria cases presented by women during pregnancy. The linked database gathered the variables from SINASC (mother age, gestational age at delivery, gravidity, number of antenatal visits, birth weight, and type of birth), with variables from SIVEP-Malaria (infection by Plasmodium spp. (yes / no) and parasite species).
Statistical analysis
Data were extracted into Microsoft Excel, and Stata 14.2 and GraphPad Prism software were used for statistical analyses. We used descriptive statistics to assess the distribution of all continuous (means and standard deviation [SD] or median and interquartile ranges [IQR]), and categorical (frequencies and percentages) variables. Differences between groups were evaluated using Mann-Whitney U-tests, accordingly. Categorical data and proportions were analyzed using chi-square tests. Every p values were 2-sided at a significance level of <0.05. To assess the association between malaria and birth weight reduction or prematurity, adjusted odds ratios (OR) with 95% confidence intervals (CI) were estimated using a multivariate logistic regression approach. These models included infections by malaria (no / yes), parasite species (no / P. vivax, P. falciparum and mixed infections), maternal age (! 18 years old / 17 years old), gravidity (primigravida / multigravida), and years of formal education (! 4 years / 3 years) as explanatory variables, and birth weight [ 10th centile] (yes / no) or LBW (yes / no) as response variables. The first category for each explanatory variable was considered as reference [24] .
Results
Study population and baseline characteristics
Between January 2006 and December 2014, 16,444 live births occurred in Cruzeiro do Sul (Acre) with a total of 3,021 malaria cases notified during pregnancy. At the end of the linkage process, 1431 (47.4%) cases of malaria were identified in pregnant women. After applying the exclusion criteria, 14,487 (88.1%) maternal-child pairs remained for further analysis (Fig 2) . Table 1 shows maternal characteristics according to infection status (detailed by year in the S1 Table) . To highlight that: circa 35% of women were primigravida; above 40% had at least 8 years of formal education (despite the high proportion of no-schooling women); and more than 70% had a minimum of four antenatal visits (Table 1 ). Nevertheless, it was possible to observe that there were no major differences between non-infected and infected mothers. Malaria incidence in the studied population was 8.9%, with P. vivax contributing to 63.9% of the cases (Fig 2) . Time series of malaria cases in pregnant women allowed to detect three epidemic peaks along the studied period, one in 2007 with more than 500 cases, and other two in 2010 and 2013 (Fig 3A and S2 Table) . Interestingly, the significant reduction of cases from 2007 to 2008 coincides with the introduction of artemisinin combined therapy in Brazil [17] . Though, P. falciparum infections represented on average more than 30% of cases reported during pregnancy, in the assessed years (S2 Table) .
Association of MiP with reduction of the newborn birth weight
The analysis of the newborn birth weight across the nine years period, allowed to observe a significant reduction in the mean weight of babies born from women that had malaria during pregnancy ( Fig 3B, Table 2 , and S3 Table) . Newborns from P. falciparum-infected mothers presented a more prominent difference of approximately 150 g (p<0.0001) when compared to newborns from non-infected women (Table 2) . Notably, the comparison of each group by year evidenced that newborns from P. vivax-infected mothers showed higher weight reduction when compared with non-infected (S3 Table) . These differences can be explained by the higher prevalence of newborns with LBW among P. vivax-infected women (term LBW: NI 4.8%, Pv 6.5%, p = 0.031; all LBW: NI 6.8%, Pv 8.9%, p = 0.020) ( Table 2 and S4 Table) . Although this prevalence occurred throughout the assessed years, it was more evident in 2006 and 2013 (S4 Table) .
Using multivariate logistic regression analysis malaria was associated with an increased odds of newborn small for gestational age (SGA) at term (weight 10th centile, boys 2758g and girls 2658g) (Odds ratio [OR] 1.23, 95%, confidence interval [CI] 1.05-1.45, p = 0.013), which relates to P. vivax infection (OR 1.24, 95% CI 1.02-1.52, p = 0.035) (Fig 4) . Moreover, LBW at term was significantly increased in newborns from malaria-infected mothers, (OR 1.34, 95% CI 1.04-1.72, p = 0.024), which was evidenced when mothers were infected by P. vivax (OR 1.39, 95% CI 1.03-1.88, p = 0.033) (Fig 4) . Additionally, segregation by gravidity showed that newborns at term from both primigravida and multigravida presented reduced birth weight when mothers had malaria during pregnancy, irrespective of species (Fig 5 and S5  Table) . Nevertheless, newborns from primigravida showed a more prominent birth weight reduction upon infection (Fig 5B and S5 Table) .
P. falciparum infection during pregnancy increases preterm births
The assembly of databases unveiled increased prematurity among babies born from P. falciparum-infected women during pregnancy (Table 2) . Prematurity prevalence increased around 3% when women were infected with P. falciparum, and the association was evidenced by multivariate logistic regression analysis (OR 1.54, 95% CI 1.09-2.18, p = 0.016), which corresponded with late preterm births (OR 1.59, 95% CI 1.11-2.27, p = 0.011) (Fig 6) . Moreover, P. vivax infections were related to very preterm births in women with malaria during pregnancy (OR 2.09, 95% CI 1.04-4.20, p = 0.039) (Fig 6) .
Together, these results demonstrate that linkage of national record databases is a valuable research tool, which disclosed adverse neonatal outcomes upon malaria infection during pregnancy in Brazil. 
Discussion
Malaria during pregnancy is known as an important risk factor for miscarriage, stillbirth, LBW and maternal anemia [9, [25] [26] [27] . Nevertheless, little is known about MiP in the Americas endemic regions, where it predominates P. vivax infections. This work is the first to assess the effect of MiP in Brazil through the linkage of national databases of the Brazilian Ministry of Health, SINASC and SIVEP-Malaria. Interestingly, despite the decrease in the number of MiP cases through the studied period (2006-2014), the impact of malaria during pregnancy is still evident. The reduction of the mean of the weight was maintained throughout the years and the higher prevalence of preterm births among newborns from women that presented malaria during pregnancy. The number of studies estimating the real frequency of MiP women is still limited, both in Brazil and in other regions of the Americas, which are considered low transmission areas [3] . The prevalence (8.9%) of malaria during pregnancy in our study was similar to the findings of a multi-centric study that enrolled data from the Americas (Guatemala, Colombia, and Brazil) between 2008-2011, and another study performed in Urubá (Colombia) between 2005-2009 [28, 29] . Though, the prevalence is higher in relation to reports from Iquitos (6.6%) (Peru), and from other Brazilian cities, such as Manaus (6.1%) and Coari (4.3%) in the Amazonas state, and Rio Branco (1.4%) in Acre state [30] [31] [32] [33] . The discrepancies may encompass differential study designs and endemicity of studied areas.
Prematurity is one of the adverse effects commonly observed in malaria during pregnancy [7, 34, 35] . Usually, it correlates with infections occurring during the third trimester of pregnancy and contributes to increasing the number of newborns with LBW, which is more likely to be observed in low transmission areas [3, 36] . In fact, our data show that P. falciparum infections during pregnancy are responsible for a high proportion of preterm births, mainly late preterm births (!32 and <37 weeks of gestation). However, it was not possible to correlate the time of infection with the gestational trimester.
Newborns reduced weight at birth either classified as LBW or SGA, is an important predictive marker of neonatal and child survival, and can result from two basic factors: intrauterine growth restriction and preterm births [35, 37] . In MiP, birth weight reduction is the main adverse outcome observed in studies involving P. falciparum infections [3, 34, 38, 39] . In our observations, malaria infection during pregnancy represents a critical morbidity that impacts newborns' weight. The records show that malaria in pregnant women increases the number of babies born at term with SGA by 19.3% and LBW by 28.6% (SGA-NI 14.0%, Malaria 16.7%; term LBW-NI 4.9%, Malaria 6.3%). Strikingly, P. vivax infection during pregnancy represents the higher odds for the occurrence of birth weight reduction (SGA-OR 1.24, 95% CI 1.02-1.52, p = 0.035; term LBW-OR 1.39, 95% CI 1.03-1.88, p = 0.033). The absence of the association between P. falciparum infections and the occurrence of SGA or LBW newborns can be related with the restricted pool of variant genes of the Amazonian parasite, which can explain the mild outcomes observed in the Americas, substantially different from other endemic regions in the world [40] . Nevertheless, our data corroborate some findings in Southeast Asia from Moore et al. that show that P. vivax infection is associated with SGA and P. falciparum infection with late preterm, although we could not correlate with time of infection [38] .
The reduction of newborns birth weight is multifactorial, and it can be related to social-economic, environmental, nutritional, and clinic factors during pregnancy. However, in this Low birth weight in malaria study, it was not possible to assess other risk factors, once these variables were absent in the databases used. Of note, it is important to highlight that it is impossible to compare this study with other carried out in Africa. There, P. falciparum infections are predominant and, in general, the health systems that diagnose and treat malaria have several limitations, summed up with the high rate of co-infection with other diseases, such as HIV and tuberculosis. The Brazilian Amazonian region has a health care system with effective strategies to control, diagnose, and treat malaria, despite being a low transmission area with predominance of P. vivax infections. These characteristics make our findings even more interesting, as we observed a substantial impact of infection during pregnancy in newborns.
In Brazil, malaria is a mandatory notification disease, and SIVEP-Malaria is essential to plan health interventions that enable effective control and preventive strategies to eradicate the disease. For pregnant women, the early diagnosis is essential to prevent adverse outcomes. In 2014, it was enforced, by Brazilian MoH, a malaria routine screen during antenatal care and at delivery, in women living in Brazilian Amazonian region states [41] . This initiative brought important benefits for both mother and fetus, enabling early treatment and preventing gestational adverse outcomes.
This work present potential limitations. First, the databases used have only two shared variables with adequate fulfillment, and this hampered the identification of all women with about 52.6% of cases not matched. Therefore, the number of pregnant women with malaria can be underestimated. Second, the reduction of birth weight has different etiologies. Although we used important exclusion criteria, it was not possible to identify through SINASC women presenting other infections, such as TORCHs, as well as, nutritional or other risk factors.
Conclusions
In conclusion, this work allowed us to observe through a population-based observational study, the effect of MiP on newborns birth weight in a region considered of low transmission and with P. vivax infections predominance. During the evaluated period (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) , malaria infections continue to be an important risk factor for prematurity and reduction of newborns' birth weight, despite the decline in the number of cases reported in the region. We have shown that the SINASC and the SIVEP-Malaria databases linkage allow to estimate the extent of malaria adverse effects, which permit to improve information and further plan interventions. These findings reinforce the urgent need for health programs and actions to prevent and protect pregnant women against the consequences of malaria, especially during the antenatal care. 
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